FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897944550> ?p ?o ?g. }

• W2897944550 endingPage "166" @default.
• W2897944550 startingPage "159" @default.
• W2897944550 abstract "Glucocorticoids are standard of care for many chronic inflammatory conditions, including juvenile dermatomyositis (JDM) and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). We sought to define pharmacodynamic biomarkers of therapeutic efficacy and safety concerns of glucocorticoid treatment for these two disorders. Previous proteomic profiling of patients with Duchenne muscular dystrophy (DMD) and inflammatory bowel disease (IBD) treated with glucocorticoids identified candidate biomarkers for efficacy and safety concerns of glucocorticoids. Serial serum samples from patients with AAV (n = 30) and JDM (n = 12) were obtained during active disease, and after treatment with glucocorticoids. For AAV, 8 of 11 biomarkers of the anti-inflammatory response to glucocorticoids were validated (P-value ≤0.05; CD23, macrophage-derived cytokine, interleukin-22 binding protein, matrix metalloproteinase-12, T lymphocyte surface antigen Ly9, fibrinogen gamma chain, angiopoietin-2 [all decreased], and protein C [increased]), as were 5 of 7 safety biomarkers (P-value ≤0.05; afamin, matrix metalloproteinase-3, insulin growth factor binding protein-5, angiotensinogen, leptin [all increased]). For JDM, 10 of 11 efficacy biomarkers were validated (P-value ≤0.05; all proteins except fibrinogen gamma chain) and 6 of 7 safety biomarkers (P-value ≤0.05; AAV proteins plus growth hormone binding protein). The identified efficacy biomarkers may be useful as objective outcome measures for early phase proof-of-concept studies when assessing novel anti-inflammatory drugs in JDM and AAV, and likely in other inflammatory disorders. Similarly, safety biomarkers may also be helpful assessing toxicity of alternatives to glucocorticoids." @default.
• W2897944550 created "2018-10-26" @default.
• W2897944550 creator A5019906559 @default.
• W2897944550 creator A5022658693 @default.
• W2897944550 creator A5024664136 @default.
• W2897944550 creator A5040081755 @default.
• W2897944550 creator A5041302124 @default.
• W2897944550 creator A5041400870 @default.
• W2897944550 creator A5048875579 @default.
• W2897944550 creator A5049312380 @default.
• W2897944550 creator A5057008464 @default.
• W2897944550 creator A5057689155 @default.
• W2897944550 creator A5061247977 @default.
• W2897944550 creator A5070954626 @default.
• W2897944550 creator A5081715473 @default.
• W2897944550 creator A5082909035 @default.
• W2897944550 date "2018-12-01" @default.
• W2897944550 modified "2023-10-17" @default.
• W2897944550 title "Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis" @default.
• W2897944550 cites W1978596895 @default.
• W2897944550 cites W2001131937 @default.
• W2897944550 cites W2007151357 @default.
• W2897944550 cites W2023980784 @default.
• W2897944550 cites W2062859034 @default.
• W2897944550 cites W2073688197 @default.
• W2897944550 cites W2153415140 @default.
• W2897944550 cites W2190845060 @default.
• W2897944550 cites W2279785978 @default.
• W2897944550 cites W2407190166 @default.
• W2897944550 cites W2474029657 @default.
• W2897944550 cites W2517949748 @default.
• W2897944550 cites W2520166953 @default.
• W2897944550 cites W2604745577 @default.
• W2897944550 cites W2626024150 @default.
• W2897944550 cites W2754941890 @default.
• W2897944550 cites W2792574008 @default.
• W2897944550 cites W2793913085 @default.
• W2897944550 cites W2793979926 @default.
• W2897944550 cites W2795151550 @default.
• W2897944550 cites W2800712653 @default.
• W2897944550 cites W2806375253 @default.
• W2897944550 cites W2892018897 @default.
• W2897944550 doi "https://doi.org/10.1016/j.steroids.2018.10.008" @default.
• W2897944550 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6640634" @default.
• W2897944550 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30352204" @default.
• W2897944550 hasPublicationYear "2018" @default.
• W2897944550 type Work @default.
• W2897944550 sameAs 2897944550 @default.
• W2897944550 citedByCount "16" @default.
• W2897944550 countsByYear W28979445502019 @default.
• W2897944550 countsByYear W28979445502020 @default.
• W2897944550 countsByYear W28979445502021 @default.
• W2897944550 countsByYear W28979445502022 @default.
• W2897944550 countsByYear W28979445502023 @default.
• W2897944550 crossrefType "journal-article" @default.
• W2897944550 hasAuthorship W2897944550A5019906559 @default.
• W2897944550 hasAuthorship W2897944550A5022658693 @default.
• W2897944550 hasAuthorship W2897944550A5024664136 @default.
• W2897944550 hasAuthorship W2897944550A5040081755 @default.
• W2897944550 hasAuthorship W2897944550A5041302124 @default.
• W2897944550 hasAuthorship W2897944550A5041400870 @default.
• W2897944550 hasAuthorship W2897944550A5048875579 @default.
• W2897944550 hasAuthorship W2897944550A5049312380 @default.
• W2897944550 hasAuthorship W2897944550A5057008464 @default.
• W2897944550 hasAuthorship W2897944550A5057689155 @default.
• W2897944550 hasAuthorship W2897944550A5061247977 @default.
• W2897944550 hasAuthorship W2897944550A5070954626 @default.
• W2897944550 hasAuthorship W2897944550A5081715473 @default.
• W2897944550 hasAuthorship W2897944550A5082909035 @default.
• W2897944550 hasBestOaLocation W28979445501 @default.
• W2897944550 hasConcept C126322002 @default.
• W2897944550 hasConcept C159654299 @default.
• W2897944550 hasConcept C163764329 @default.
• W2897944550 hasConcept C203014093 @default.
• W2897944550 hasConcept C2776015282 @default.
• W2897944550 hasConcept C2778552304 @default.
• W2897944550 hasConcept C2778751314 @default.
• W2897944550 hasConcept C2779134260 @default.
• W2897944550 hasConcept C2780841215 @default.
• W2897944550 hasConcept C2781197716 @default.
• W2897944550 hasConcept C55493867 @default.
• W2897944550 hasConcept C71924100 @default.
• W2897944550 hasConcept C86803240 @default.
• W2897944550 hasConceptScore W2897944550C126322002 @default.
• W2897944550 hasConceptScore W2897944550C159654299 @default.
• W2897944550 hasConceptScore W2897944550C163764329 @default.
• W2897944550 hasConceptScore W2897944550C203014093 @default.
• W2897944550 hasConceptScore W2897944550C2776015282 @default.
• W2897944550 hasConceptScore W2897944550C2778552304 @default.
• W2897944550 hasConceptScore W2897944550C2778751314 @default.
• W2897944550 hasConceptScore W2897944550C2779134260 @default.
• W2897944550 hasConceptScore W2897944550C2780841215 @default.
• W2897944550 hasConceptScore W2897944550C2781197716 @default.
• W2897944550 hasConceptScore W2897944550C55493867 @default.
• W2897944550 hasConceptScore W2897944550C71924100 @default.
• W2897944550 hasConceptScore W2897944550C86803240 @default.
• W2897944550 hasFunder F4320306700 @default.
• W2897944550 hasFunder F4320306741 @default.

• next